Yahoo
Stockholm - Free Realtime Quote SEK

Surgical Science Sweden AB (publ) (SUS.ST)

59.35 +0.50 (+0.85%)
As of 9:03:36 AM GMT+1. Market Open.
Chart Range Bar
Loading chart for SUS.ST
  • Previous Close 58.85
  • Open 59.00
  • Bid 58.15 x --
  • Ask 59.30 x --
  • Day's Range 58.20 - 60.00
  • 52 Week Range 23.70 - 85.85
  • Volume 6,467
  • Avg. Volume 208,607
  • Market Cap (intraday) 3.028B
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) 32.61
  • EPS (TTM) 1.82
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 68.60

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.

www.surgicalscience.com

319

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

SUS.ST
82.62%
OMX Stockholm 30 Index (^OMX)
13.01%

1-Year Return

SUS.ST
29.35%
OMX Stockholm 30 Index (^OMX)
17.74%

3-Year Return

SUS.ST
55.71%
OMX Stockholm 30 Index (^OMX)
54.35%

5-Year Return

SUS.ST
77.08%
OMX Stockholm 30 Index (^OMX)
41.49%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 254.52M
Earnings 20.85M
Profit Margin 8.19%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
50M
100M
150M
200M
250M
8.0%
9.0%
10.0%
11.0%
12.0%

Analyst Insights

View More

Analyst Price Targets

60.00
68.60 Average
59.35 Current
85.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.11%

  • Return on Assets (ttm)

    2.00%

  • Return on Equity (ttm)

    2.10%

  • Revenue (ttm)

    1.02B

  • Net Income Avi to Common (ttm)

    93.14M

  • Diluted EPS (ttm)

    1.82

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    658.39M

  • Total Debt/Equity (mrq)

    0.06%

  • Levered Free Cash Flow (ttm)

    30.16M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: